申请人:——
公开号:US20040044056A1
公开(公告)日:2004-03-04
This invention relates to the compounds represented by a general formula [I]:
1
[in which A
1
and A
2
represent optionally fluorine-substituted methine or the like; B represents halogen, cyano, lower alkyl or the like; D represents optionally substituted heterocyclic group or the like; and G represents C
3
-C
20
aliphatic group such as alicyclic group]. These compounds inhibit nociceptin activities due to their high affinity to nociceptin receptor, and are useful as analgesic, antiobestic, corebral function improver, drugs for treatment of alzheimer's disease and dementia, remedies for schizophrenia and neurodegenerative diseases, antidepressant, remedies for diabetes insipidus, polyuria, hypotension and so on.
本发明涉及由一般式[I]表示的化合物:1[其中,A1和A2表示选择性氟代甲基或类似物;B表示卤素,氰基,低碳烷基或类似物;D表示选择性取代的杂环基团或类似物;G表示C3-C20脂肪族基团,例如脂环族基团]。这些化合物由于对痛觉受体具有高亲和力而抑制了痛觉肽活性,并且可用作镇痛剂,抗肥胖剂,脑功能改善剂,治疗阿尔茨海默病和痴呆症的药物,治疗精神分裂症和神经退行性疾病的药物,抗抑郁剂,治疗尿崩症,多尿症,低血压等的药物。